THOR Integrated Device With a unique world-first ability to perform laser atherectomy and laser-based intravascular ...

Abbott has delivered new, longer-term data from a clinical study of its dissolving stent for severe peripheral artery disease ...

"Abbott touts long-term efficacy for dissolvable Esprit BTK stent" was originally created and published by Medical Device ...

Heart disease is expected to affect 61% of US adults by 2050, so it’s important to know when problems may be afoot.

Learn about Peripheral Artery Disease (PAD) and its impact on the Black community. Discover the risks, symptoms, and treatment options for this irreversible medical condition.

Peripheral artery disease, or PAD, is a condition that can cause blood flow in your limbs to become restricted or even ...

This is the first hospital in North Texas to offer the treatment for patients suffering from complex peripheral artery ...

Philips announced the first U.S. treatment using its new laser device that combines two peripheral artery disease (PAD) procedures into one.

Royal Philips announced enrollment of the first patient in THOR, a United States investigational device exemption (IDE) clinica ...

Following a greenlight from the US FDA, Philips has enrolled the first patient in a trial of its newest intravascular ...

A risk model accurately identifies patients with severe asymptomatic carotid artery stenosis and predicts their risk for stroke and CVD.

Gains from its Bitcoin holdings contributed notably to EPS growth. Semler Scientific produces the QuantaFlo -- a non-invasive ...